CA2103703A1 - Peptides - Google Patents

Peptides

Info

Publication number
CA2103703A1
CA2103703A1 CA002103703A CA2103703A CA2103703A1 CA 2103703 A1 CA2103703 A1 CA 2103703A1 CA 002103703 A CA002103703 A CA 002103703A CA 2103703 A CA2103703 A CA 2103703A CA 2103703 A1 CA2103703 A1 CA 2103703A1
Authority
CA
Canada
Prior art keywords
peptide
amino
peptides
alkyl
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002103703A
Other languages
English (en)
Inventor
Michael J. Tyler
John H. Bowie
David J. M. Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luminis Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2103703A1 publication Critical patent/CA2103703A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
CA002103703A 1991-02-12 1992-02-12 Peptides Abandoned CA2103703A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK4561 1991-02-12
AUPK456191 1991-02-12

Publications (1)

Publication Number Publication Date
CA2103703A1 true CA2103703A1 (fr) 1992-08-13

Family

ID=3775221

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002103703A Abandoned CA2103703A1 (fr) 1991-02-12 1992-02-12 Peptides

Country Status (4)

Country Link
EP (1) EP0579611A4 (fr)
JP (1) JPH06507602A (fr)
CA (1) CA2103703A1 (fr)
WO (1) WO1992013881A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735983B1 (fr) 1995-06-29 1997-12-05 Centre Nat Rech Scient Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
DK1664095T3 (da) * 2003-06-11 2009-04-06 Novozymes As Antimikrobielle polypeptider
EP1664096B1 (fr) * 2003-06-11 2009-10-14 Novozymes A/S Polypeptides antimicrobiens
CN100522993C (zh) * 2006-05-30 2009-08-05 中国科学院昆明动物研究所 无指盘臭蛙抗菌肽
CN102516382B (zh) * 2011-12-26 2014-04-16 大连理工大学 一种海南湍蛙抗微生物肽Hainanenin-5及其基因、应用
CN106749594B (zh) * 2016-12-27 2020-02-14 王天放 包含f1、f3多肽的药物组合物及其在治疗hpv感染疾病中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485850T2 (de) * 1983-11-08 1993-01-21 Teijin Ltd Genfragmente, abgeleitet vom menschlichen immunoglobulin-gen.
JPS62129297A (ja) * 1985-08-09 1987-06-11 Toyo Jozo Co Ltd カルシトニン遺伝子関連ペプチド誘導体
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0330359A3 (fr) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition utile pour le diagnostic et le traitement de l'infection par le HIV-I
JPH02262595A (ja) * 1988-02-29 1990-10-25 Otsuka Pharmaceut Co Ltd ポリペプチド誘導体
DE3935572A1 (de) * 1989-10-25 1991-05-02 Biotechnolog Forschung Gmbh Verfahren zur peptidsynthese und traeger dafuer

Also Published As

Publication number Publication date
WO1992013881A1 (fr) 1992-08-20
JPH06507602A (ja) 1994-09-01
EP0579611A4 (fr) 1995-04-19
EP0579611A1 (fr) 1994-01-26

Similar Documents

Publication Publication Date Title
US5840688A (en) Eating suppressant peptides
US5420109A (en) Cytokine restraining agents
KR101306643B1 (ko) 항미생물성 헥사펩티드
CN114269769B (zh) 新型肽化合物或其药学上可接受的盐
US10919935B2 (en) Antimicrobial peptide derived from myxinidin peptide and uses thereof
US6524585B1 (en) Indolicidin analogs and methods of using same
Kim et al. Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio
ES2296342T3 (es) Tratamiento de la obesidad.
JP2805194B2 (ja) 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
US6429296B2 (en) Complex of human growth hormone and zinc and use
CA2103703A1 (fr) Peptides
CA2072253A1 (fr) Peptides anti-inflammatoires et traitement destines a empecher les ecoulements des vaisseaux dans les tissus leses
US12371459B2 (en) Antimicrobial peptide derived from Pseudin-2 peptide and uses thereof
KR101980897B1 (ko) Ll37 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
WO1995027728A1 (fr) Peptides
US6046168A (en) Peptide inhibits blood triglyceride level
JPH04266899A (ja) ヒトリポコルチンから誘導される合成ペプチド及びその用途
AU1253292A (en) Peptides
JPH06502385A (ja) 血管拡張及び免疫抑制ペプチド
US7371810B1 (en) Tachykinin peptides, precursor peptides thereof and genes encoding the same
JPS6322524A (ja) 鎮痛剤として有用な環状及び架橋環状ソマトスタチンアナログ
WO1999065510A1 (fr) Analogues d'indocilidine stabilises par reticulation
CA1049942A (fr) Complexe enzyme-hormone extrait de l'intestin grele
KR20230040782A (ko) 항염증 효능을 가지는 곤충유래 프로테티아마이신-9 펩타이드 및 이의 용도
AU678329C (en) Cytokine restraining agents

Legal Events

Date Code Title Description
FZDE Dead